Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Bva02g00434 ATGGATGCCTCTTCTCCCATGTCCCTCCAAAAGGCGACACCGTTTCAAGACCTCCCACAAGCTTCCCCAAAACCATACAGGAAAAGCTTCGTCACTACTTTAATGGAAGCCGCCACTCTCCGAACCCCTTCATTCAAAGAAGACACCTACTTCATTTCCCACTTGAAGTCTTCCGAGAAGAAAGCCCTGCAAGAGCTCAAAGACAAGCTCTCGGCTTCTGAAGCCTCTGATTCCTCAATGTGGGGTATTCCTCTTCTTGGTGGCGATGACAAAGCTGATGTGATTCTCTTGAAGTTTCTCAGAGCCAGAGATTTCCGAGTTGGAGATGCTCTCAACATGCTCCTCAAGTGCTTGGCTTGGAGGAAAGAGTTTGGAGCTGATAACATCACTGAACAAGACTTGGGCTTCAAAGAACTTGAAGGGGTGATTGCTTATATGCAAGGCTATGACAAGGAGGGACACCCCGTTTGCTATAATGCTTATGGGGTTTTCAGAGACAAAGAAATGTATGAAAGAGTATTTGGAGATGAAGAGAAGCTGAAGAAATTCCTCAAGTGGAGAGTTCAGGTTCTAGAAAGAGGAATCAAGCTTCTCCATTTCAAGCCTGGTGGGGTTAACTCTATCATTCAGGTCACTGACCTGAAAGACATGCCAAAAAAGGAGCTCAGGGTAGCTTCTAATCAGATCCTGTCTCTTTTCCAAGACAATTACCCAGAAATGGTGGCTCGCAagATTTTCATCAACGTTCCATGGTACTTCAGCGTGTTATATTCAATGTTCAGTCCGTTTCTGACTCAACGAACCAAGAGTAAGTTTGTGATCTCTAAGGAAGGAAATGTTGCAGAGACACTCTACAAATTCGTAAGGCCTGAGGACATTCCTGTTCAGTATGGAGGACTCAGTCGTCCTAGCGATTTGCAGAATGGTCCCCCGAAGCCTGCTTCTGAATTCACTGTCAAAGGAGGGGAAAAAGTGAACATACAGATTGAAGGAATTGagGGAGGTGCAACAATTACATGGGACATTGTGGTTGGTGGTTGGGACTTGGAATACAGTGCAGAGTTTGTTCCTGTTGCAGAAGGCAGCTACACCATAGCAGTGGAGAAGCCAAGGAAAATTGGTGCCTCAGAAGAAGCAATTCACAACTCATACACTTCAAAAGAAGCTGGCAAAATGGTACTCTCTGTGGACAACACTGCCTCTAGGAGGAAAAAGGTCGCTGCATATCGCTACATCGTCCGCAAATCCAGTACTGTCTG 1259 0.4551 MDASSPMSLQKATPFQDLPQASPKPYRKSFVTTLMEAATLRTPSFKEDTYFISHLKSSEKKALQELKDKLSASEASDSSMWGIPLLGGDDKADVILLKFLRARDFRVGDALNMLLKCLAWRKEFGADNITEQDLGFKELEGVIAYMQGYDKEGHPVCYNAYGVFRDKEMYERVFGDEEKLKKFLKWRVQVLERGIKLLHFKPGGVNSIIQVTDLKDMPKKELRVASNQILSLFQDNYPEMVARKIFINVPWYFSVLYSMFSPFLTQRTKSKFVISKEGNVAETLYKFVRPEDIPVQYGGLSRPSDLQNGPPKPASEFTVKGGEKVNIQIEGIEGGATITWDIVVGGWDLEYSAEFVPVAEGSYTIAVEKPRKIGASEEAIHNSYTSKEAGKMVLSVDNTASRRKKVAAYRYIVRKSSTV 419
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Bva02g00434 419 Gene3D GOLD domain 312 413 - -
Bva02g00434 419 SUPERFAMILY Supernatant protein factor (SPF), C-terminal domain 316 416 IPR036598 -
Bva02g00434 419 Pfam CRAL/TRIO domain 140 299 IPR001251 -
Bva02g00434 419 CDD SEC14 136 300 IPR001251 -
Bva02g00434 419 Gene3D - 51 123 - -
Bva02g00434 419 SMART CRAL_TRIO_N_2 92 117 IPR011074 -
Bva02g00434 419 Coils Coil 56 76 - -
Bva02g00434 419 Gene3D - 130 311 IPR036865 -
Bva02g00434 419 MobiDBLite consensus disorder prediction 1 23 - -
Bva02g00434 419 SUPERFAMILY CRAL/TRIO domain 138 302 IPR036865 -
Bva02g00434 419 PANTHER PATELLIN-1 11 417 IPR044834 GO:0008289
Bva02g00434 419 Pfam CRAL/TRIO, N-terminal domain 62 115 IPR011074 -
Bva02g00434 419 ProSiteProfiles CRAL-TRIO lipid binding domain profile. 131 305 IPR001251 -
Bva02g00434 419 SUPERFAMILY CRAL/TRIO N-terminal domain 46 132 IPR036273 -
Bva02g00434 419 MobiDBLite consensus disorder prediction 1 17 - -
Bva02g00434 419 SMART sec14_4 138 302 IPR001251 -
Bva02g00434 419 ProSiteProfiles GOLD domain profile. 281 415 IPR009038 -
Bva02g00434 419 PANTHER PATELLIN-6 11 417 - -
       

Duplication type information

Select Gene Chromosome Start End Duplicated_type
Bva02g00434 Bva-Chr2 5914635 5916990 Transposed
       

Functional genes information

Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Bva02g00434 96 271 Acyl Lipid Metabolism Gene Families AT5G47730 28.649 7.17e-12 64.3
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Bva02g00434 - - qsu:112015166 753.821
       

Event-related genes

Select Gene_1 Chr_1 Start_1 End_1 Gene_2 Chr_2 Start_2 End_2 Event_name
Bva02g00434 02 5914635 5916990 Bva02g00434 02 5914635 5916990 ECH